EU lists rare nerve disorder as side-effect of J&J COVID-19 vaccine

(Reuters) – Europe’s medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson’s (JNJ.N) COVID-19 vaccine after it reviewed 108 cases reported worldwide.

FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

“After assessing the available data, PRAC considered that a causal relationship between COVID-19 vaccine Janssen and GBS is possible,” the European Medicines Agency said, referring to its safety committee, PRAC.

Reporting by Pushkala Aripaka in Bengaluru; editing by Uttaresh.V

Our Standards: The Thomson Reuters Trust Principles.

 

Reuters source:

https://www.reuters.com/business/healthcare-pharmaceuticals/eu-lists-rare-nerve-disorder-side-effect-jj-covid-19-vaccine-2021-07-22